# Biomat USA, Inc. – FDA Inspection, Sep 20, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/75a1483f-2a61-4661-84b0-11d22d24148e
Source feed: FDA_Inspections

> FDA inspection 745721 of Biomat USA, Inc., September 20, 2011. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 745721
- Company Name: Biomat USA, Inc.
- Inspection Date: 2011-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1256896 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3d2596d9-c59c-4357-ba91-21c438e15d5f)
- FDA Inspection 1094894 - 2019-06-06
- FDA Inspection 945499 - 2015-09-18
- FDA Inspection 573575 - 2009-03-25

Company: https://www.keypedia.com/companies/biomat-usa-inc/3f431465-eedc-461b-adf4-3aa8816d34f0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
